15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Amdocs Ltd, 3 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $71.00 to $97.00, so the covering firms are broadly aligned. The average target of $86.67 sits 58% above the current $54.87. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.98 next quarter toward $8.06 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy360%
Hold240%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Amdocs Ltd.
As of Jul, 3 of 5 firms rate DOX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DOX EPS & revenue forecast
EPS · NEXT QUARTER
$1.98
Range $1.90 – $2.01 · 5 analysts · +8% YoY
Next period, 5 analysts expect Amdocs Ltd to earn $1.98 a share (range $1.90 – $2.01), versus $1.83 a year earlier. Full-year consensus is $7.41, growing to $8.06 the year after.
REVENUE · NEXT QUARTER
$1.2B
Range $1.2B – $1.2B · 5 analysts · +3% YoY
Revenue is expected to reach $1.2B (range $1.2B – $1.2B), +3.4% year-over-year. Full-year consensus is $4.7B, rising to $4.8B next year.
Top analysts covering Amdocs Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DOX.
#1
Shlomo Rosenbaum
Stifel
Buy
$71.00+29.4% to target
Coverage
—
+ Follow
#2
TR
Tavy Rosner
Barclays
Buy
$92.00+67.7% to target
Coverage
—
+ Follow
#3
GN
George Notter
Wolfe Research
Hold
No targeton DOX
Coverage
—
+ Follow
#4
Timothy Horan
Oppenheimer
Buy
$105.00+91.4% to target
Coverage
—
+ Follow
#5
DA
Devin Au
Keybanc
Hold
No targeton DOX
Coverage
—
+ Follow
DOX stock forecast FAQ
What is DOX's average 12-month price target?+
The 3 analysts with a live target average $86.67 for Amdocs Ltd over the next 12 months, ranging from a $97.00 high to a $71.00 low.
Is DOX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 3 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DOX?+
The Street-high target is $97.00 (B of A Securities), and the Street-low is $71.00 (Stifel). The average of all 3 active targets is $86.67.
How many Wall Street analysts cover DOX?+
5 analysts have an active rating on Amdocs Ltd, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering DOX?+
Among analysts who currently cover DOX, Shlomo Rosenbaum of Stifel has the strongest overall Quantellect track record. Their current call is Buy with a $71.00 target.
What is Amdocs Ltd's projected EPS for next quarter?+
The consensus estimate is $1.98 per share (range $1.90 – $2.01) across 5 analysts. Full-year EPS is projected at $7.41, rising to $8.06 the following year.
How much revenue is Amdocs Ltd expected to report next quarter?+
Consensus revenue is $1.2B (range $1.2B – $1.2B). Full-year revenue is projected at $4.7B, growing to $4.8B next year.
Have analysts been upgrading or downgrading DOX lately?+
As of Jul, 3 of 5 firms rate DOX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DOX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
